Episode 76
Biotech Hangout
00:00
Analyzing the Stock Drop of Ventix Bioscience
The hosts discuss the recent stock drop of Ventix Bioscience and speculate on the reasons behind it, including the difference between expected and actual results, and nervousness about upcoming phase two data. They also highlight the importance of comparing phase two data sets to determine differentiation and superiority.
Transcript
Play full episode
